Eurofins GeneScan Holding GmbH

What Eurofins GeneScan Holding GmbH does

Eurofins GeneScan Holding GmbH is a German holding entity within the Eurofins Scientific SE group, a global provider of bioanalytical laboratory testing services founded in 1987 by Dr. Gilles G. Martin in Nantes, France. The group operates 950+ accredited laboratories across 59 countries with over 65,000 employees, delivering testing services across food & feed, BioPharma, clinical diagnostics, cosmetics & personal care, environment, genomic services, agroscience, consumer products, forensic, materials & engineering sciences, in vitro diagnostics, and assurance/certification. Its portfolio includes over 200,000 validated analytical methods, including proprietary technologies such as SNIF-NMR for food authenticity, GM fish detection, heavy metals detection, and non-invasive prenatal testing methods.

The business model is built on a decentralized, entrepreneur-led structure where local laboratory presidents run their businesses with autonomy, supported by a centralized Group Operating Council, Regional and National Business Line Leaders, and cross-border coordination for international clients. Revenue is generated primarily through fee-for-service laboratory testing (described in source as subscription/recurring), audit/certification services, and increasingly through IVD product sales via subsidiaries such as Gold Standard Diagnostics. Pricing is quote-based rather than publicly disclosed, with services customized per client requirement. Distribution operates through direct enterprise field sales and sample-submission to local labs, complemented by digital marketing, scientific publications, industry events, and regional sales leadership across global markets.

Recent strategic activity includes the December 2025 divestiture of the Electrical & Electronic Testing business (MET Labs) to UL Solutions for €575 million, the 2025 appointment of Etienne Roux as Executive Vice President overseeing Environment, Tribology, Clinical Diagnostics, and Agroscience/Forensic/Genomic Services in Europe, and product launches aligned with regulatory catalysts (Bemotrizinol Testing Services tied to FDA approval in 2026, FSSC 22000 Version 7 support services in May 2025). The parent Eurofins Scientific SE is publicly traded on Euronext Paris (ticker: ERF).

Name

Eurofins GeneScan Holding GmbH

Legal name

Eurofins GeneScan Holding GmbH

Website

https://eurofins.com

Company type

Public

Founded year

1987

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Eurofins GeneScan Holding GmbH is a German subsidiary of Eurofins Scientific SE, a global bioanalytical laboratory testing group operating 950+ labs across 59 countries with 65,000+ employees serving food, pharma, cosmetics, clinical, environmental, and consumer products sectors.

Ownership category

akta.pro rank

Product category

Laboratory Testing Services

NAICS

Testing Laboratories and Services (541380), Medical Laboratories (621511)

SIC

Services-Testing Laboratories (8734), Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Food Testing Laboratories (Microbiological, Chemical, Allergen) (AFALAAAA)

akta.pro secondary industries

Specialty Certification Services (Organic, Non-GMO, Halal, Kosher, Gluten-Free) (AFALAAAM), Labeling, Nutrition Facts & Allergen Verification Services (AFALAAAH), Regulatory Consulting & Compliance Program Management (FDA/USDA/EFSA) (AFALADAC), Food Testing, Laboratory Oversight & Method Standards (HLAJAEAF)

Keywords

• Bioanalytical laboratory testing
• Food safety testing
• Pharmaceutical analytical services
• Clinical diagnostics testing
• Environmental compliance testing

Headquarters

HQ city

Freiburg Im Breisgau

HQ country

Germany

HQ region

Europe

Offices25 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Laboratory Testing Services: Eurofins provides comprehensive laboratory testing services across multiple sectors including food, pharma, cosmetics, environment, genomics, and clinical diagnostics. Revenue is generated through testing fees, analysis services, and certification/audit services.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Eurofins GeneScan Holding GmbH operates within the Eurofins Scientific group network that delivers worldwide laboratory testing services spanning bioanalytical testing for food and feed, pharmaceuticals and biopharma, environment, cosmetics and personal care, clinical diagnostics, genomics, agroscience, forensic, materials and engineering, and consumer products. The company sells testing, analysis, certification, and audit services delivered through accredited laboratories, supported by proprietary analytical methods and instruments. Customers are enterprises in regulated industries such as food production, pharmaceuticals, cosmetics, and environmental management.

Product overview

Eurofins Scientific is a worldwide laboratory testing services company operating 950+ laboratories across 59 countries with over 65,000 employees. The company provides a comprehensive portfolio of testing services organized into distinct business lines including Food & Feed Testing, BioPharma Services (CDMO, Pharma Discovery, Medical Device Testing), Clinical Diagnostics (Europe, India, USA), Cosmetics & Personal Care Product Testing (with specialized services like regulatory toxicology, clinical studies, cosmetogenomics), Environment Testing (water, air, soil, pollution), Genomic Services (NGS, gene synthesis), Agroscience Services, Consumer Product Testing, Forensic Services, Materials and Engineering Sciences (via Eurofins EAG Laboratories), In Vitro Diagnostics Solutions (Gold Standard Diagnostics), Assurance Services (certification, audits, training), Electrical & Electronics Testing, REACH Services, and Maritime Services. The decentralized, entrepreneur-led operating model allows each business unit to operate with significant autonomy while leveraging the global network's scale and expertise.

Differentiator

Problem solved

Functional benefit

Brands

• EAG Laboratories: Materials testing and engineering sciences services with over 40 years experience, offering consultative multi-disciplinary approach to solving materials and engineering-related product problems
• Gold Standard Diagnostics
• Eurofins Assurance
• Eurofins Cosmetics & Personal Care
• Eurofins Professional Scientific Services (PSS)

Products and services

• Food and Feed Testing
• BioPharma Services
• Clinical Diagnostics
• Cosmetics and Personal Care Product Testing
• Environment Testing
• Genomic Services
• Agroscience Services
• Consumer Product Testing
• Forensic Services
• Eurofins EAG Laboratories (Materials and Engineering Sciences)
• Eurofins Assurance
• In Vitro Diagnostics Solutions
• REACH Services
• Maritime Services

Quantifiable outcome

• 20 Million tests per month capacity during COVID-19 pandemic
• +1 more outcomes

Segments13 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• UL Solutions Inc.divestment transactionOthers · 24 December 2025Eurofins divested its Electrical & Electronic Testing business (MET Labs) to UL Solutions Inc. for €575 million. This represents a strategic divestment of a business unit rather than a partnership, with the transaction expected to close with revenue generation of over €180 million in 2026 from the divested business.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Bureau Veritas: Bureau Veritas is a global TIC incumbent with marine, commodity, agri-food, and consumer products testing; it competes with Eurofins across multiple end-markets and shares a comparable B2B enterprise sales model and accreditation-led moat.
• ALS Limited: ALS provides food, pharmaceutical, environmental, and life sciences testing services globally; it competes with Eurofins across multiple verticals with a comparable laboratory-network business model.
• Intertek Group plc: Intertek is a global TIC player with overlapping services in food, agri, pharma, and consumer products testing; it competes directly for similar enterprise clients and pursues a comparable acquisitive expansion strategy.
• SGS SA: SGS is the world's largest Testing, Inspection & Certification (TIC) company with a comparable global footprint and overlapping food, pharma, environment, cosmetics, and consumer product testing portfolios — the most direct competitive analogue to Eurofins.
• Mérieux NutriSciences: Mérieux NutriSciences specializes in food safety, quality, and authenticity testing globally and is the closest direct specialist competitor to Eurofins' Food & Feed Testing business line.

Emerging players

• IDEXX Laboratories: IDEXX is a leader in veterinary diagnostics and water testing, with overlapping exposure to Eurofins' Animal Health and Environment Testing segments though a narrower overall portfolio.
• Bio-Rad Laboratories: Bio-Rad provides clinical diagnostics and life science research products; its clinical diagnostics and quality-control reagents intersect with Eurofins' Clinical Diagnostics and IVD Solutions offerings.

Broad incumbents

• Charles River Laboratories: Charles River is a leading contract research organization serving pharma and biotech clients, comparable to Eurofins' BioPharma Services and Discovery/preclinical testing offerings.
• Laboratory Corporation of America (Labcorp): Labcorp is one of the largest clinical laboratory networks globally and competes with Eurofins' Clinical Diagnostics business in patient testing services, particularly in North America.
• TÜV SÜD: TÜV SÜD is a large German-based testing, certification, and inspection group that overlaps with Eurofins in food, pharma, and product testing while operating a broader industrial certification portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UC3oVIVKL7queebN837SthvA
• LinkedInlinkedin.com/company/eurofins

Compliance20 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eurofins GeneScan Holding GmbH